Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Righter, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Righter, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of Antimicrobial Chemotherapy (1987) 20, 595-597
© 1987 The British Society for Antimicrobial Chemotherapy


research-article

Ciprofloxacin treatment of Staphylococcus aureus infections

Julie Righter

Toronto East General and Orthopaedic Hospital and Department of Microbiology, University of Toronto Canada

accepted 11 April 1987


Correspondence to: Dr. J. Righter, Head, Division of Microbiology, Toronto East General and Orthopaedic Hospital, 825 Coxwell Avenue, Toronto, Canada, M4C 3E7

Ciprofloxacin appears to be safe and effective for a wide variety of clinical infections. In-vitro and animal studies point to high cure rates for both methicillin-sensitive and methicillin-resistant Staphylococcus aureus infections. Seventeen patients with staphylococcal infections severe enough to require hospital admission and initial parenteral therapy were treated with ciprofloxacin; the results were poor, with clinical failure in five and bacteriological failure in 12. All pathogens isolated were susceptible to ciprofloxacin both before and after therapy and tolerance was not detected. Further study is required before ciprofloxacin can be recommended for life threatening staphylococcal infections.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Arch Intern MedHome page
N. Joshi and D. Milfred
The Use and Misuse of New Antibiotics: A Perspective
Arch Intern Med, March 27, 1995; 155(6): 569 - 577.
[Abstract] [PDF]


Home page
ANN INTERN MEDHome page
M. Trucksis, D. C. Hooper, and J. S. Wolfson
Emerging Resistance to Fluoroquinolones in Staphylococci: An Alert
Ann Intern Med, March 1, 1991; 114(5): 424 - 426.
[Abstract] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.